MET and neoplasm: Likewise, these HGF-mediated phosphorylation signals were partially diminished by a parallel incubation with 2.5 μM crizotinib and even more reduced in the presence of 1.25 μM foretinib (Fig. 4) suggesting the c-Met inhibitor foretinib a potent signaling inhibitor in these tumor cells.